Introduction
Ryanodine Receptor is an important component in the neurobiology of neurodegenerative [diseases](/diseases). This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
The ryanodine receptor (RyR) is the largest known ion channel, a massive homotetrameric calcium-release channel located in the endoplasmic reticulum (ER) membrane that regulates intracellular calcium signaling. In [neurons](/entities/neurons), RyR-mediated calcium release plays critical roles in synaptic plasticity, neurotransmitter release, gene expression, and neuronal survival. Dysregulated RyR function is increasingly implicated in [Alzheimer's disease](/diseases/alzheimers-disease) and other neurodegenerative disorders, where calcium dyshomeostasis represents a fundamental pathological mechanism [@bhatt2014]). [@bhatt2017]
Emerging evidence links RyR dysfunction to both familial and sporadic AD through interactions with presenilins [@bhatt2014]; Bhatt & bhatt 2023[@bhatt2023]). [@bhatt2021]
Molecular Architecture
Each RyR subunit (~565 kDa) is among the largest [proteins](/proteins) in the cell. The homotetramer (~2.2 MDa) forms a massive mushroom-shaped structure spanning the ER membrane: [@bhatt2023]
- Cytoplasmic domain (~80% of mass): Large regulatory region containing binding sites for Ca2+, calmodulin, FK506-binding proteins (FKBPs/calstabins), and modulatory kinases
- Transmembrane domain: Contains 6 transmembrane helices per subunit forming the ion pore
- Luminal domain: Interacts with ER luminal proteins and senses luminal calcium
| Isoform | Primary Expression | Brain Expression | Disease Association | [@fill2002]
|---------|-------------------|-----------------|---------------------| [@bhatt2011]
| RyR1 | Skeletal muscle | Motor [neurons](/entities/neurons), [cerebellum](/brain-regions/cerebellum) | Malignant hyperthermia; central core disease | [@bhatt2007]
| RyR2 | Cardiac muscle | [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), [striatum](/brain-regions/striatum) | Arrhythmias; [Alzheimer's disease](/diseases/alzheimers-disease) | [@bhatt2022]
| RyR3 | Brain (widespread) | [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), [cerebellum](/brain-regions/cerebellum), [thalamus](/brain-regions/thalamus) | Less characterized; may compensate for RyR2 | [@bhatt2020]
RyR2 is the most extensively studied neuronal isoform and the most abundant RyR in the brain, with highest expression in hippocampal CA1 [neurons](/entities/neurons) and cortical pyramidal cells - regions vulnerable to AD pathology. [@bhatt2019]
Calcium Signaling Function
Calcium-Induced Calcium Release (CICR)
RyRs mediate calcium-induced calcium release (CICR), an amplification mechanism where small cytosolic calcium signals trigger larger ER calcium release: [@bhatt2025]
An initial calcium trigger (from voltage-gated channels, NMDA] receptors, or IP3 receptors) reaches RyR
Calcium binds to cytoplasmic activation sites on RyR
The channel opens, releasing stored ER calcium into the cytoplasm
Released calcium can further activate adjacent RyRs, producing calcium waves
At high cytoplasmic calcium concentrations, RyR is inhibited (bell-shaped calcium sensitivity)
- Synaptic plasticity: RyR-mediated calcium release contributes to [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation) and long-term depression (LTD) in the [hippocampus](/brain-regions/hippocampus)
- Neurotransmitter release: Amplifies presynaptic calcium signals to enhance vesicle fusion
- Gene expression: Calcium-dependent activation of CREB and other transcription factors
- Dendritic integration: Calcium waves in dendrites modulate synaptic integration
- Neuronal excitability: Regulates afterhyperpolarization and spike frequency adaptation
Channel Regulation
RyR activity is modulated by a multiprotein regulatory complex:
- Calstabin2 (FKBP12.6): Stabilizes the channel in the closed state; prevents pathological calcium leak
- Calmodulin (CaM): Binds RyR and inhibits channel opening at resting calcium levels
- PKA/CaMKII: Phosphorylation of RyR2 increases channel open probability
- S-nitrosylation: Redox modification that sensitizes the channel
- ER luminal calcium: High luminal calcium promotes channel opening
Role in Alzheimer's Disease
Presenilin-RyR Interaction
Familial AD (FAD) mutations in [presenilin 1 [@bhatt2014])
RyR2 Post-Translational Remodeling in AD
A critical mechanism links RyR2 channel remodeling to AD pathology [@bhatt2017]):
PKA hyperphosphorylation: Chronic beta-adrenergic/stress signaling phosphorylates RyR2 at Ser2808
Oxidation and nitrosylation: Oxidative stress modifies RyR2 cysteine residues
Calstabin2 depletion: Post-translational modifications cause calstabin2 dissociation from the channel complex
Pathological calcium leak: The destabilized channel becomes "leaky," continuously releasing ER calcium
Downstream pathology: Chronic calcium leak activates:
- Calcineurin-dependent tau] dephosphorylation and redistribution
- Calpain-mediated [CDK5](/genes/cdk5) activation and tau] hyperphosphorylation
- ER stress and [unfolded protein response](/mechanisms/endoplasmic-reticulum-stress) ([UPR](/mechanisms/endoplasmic-reticulum-stress) activation
- Enhanced [BACE1
Altered RyR Expression in AD
- RyR2 expression is upregulated in [mild cognitive impairment](/diseases/mci) (MCI) and early AD stages
- This upregulation may represent a compensatory response to initial calcium perturbations
- In advanced AD, RyR expression normalizes or decreases as [neurons](/entities/neurons) degenerate
- Regional differences: Greatest RyR changes in [hippocampus](/brain-regions/hippocampus) and temporal [cortex](/brain-regions/cortex)
Feed-Forward Pathological Cycle
RyR dysfunction creates a self-amplifying pathological cascade:
- ER calcium leak increases cytosolic calcium, promoting Aβ] production
- [Aβ](/proteins/amyloid-beta) oligomers further dysregulate RyR and increase calcium entry
- Elevated calcium activates tau kinases ([GSK-3β](/entities/gsk3-beta), [CDK5)
- [Tau](/proteins/tau)(/proteins/tau hyperphosphorylation impairs neuronal function
- ER stress activates inflammatory and apoptotic pathways
Therapeutic Targeting
Rycal Compounds (RyR Stabilizers)
A novel class of drugs called Rycals (e.g., ARM210/S107, ARM036) stabilize the closed state of RyR by preventing calstabin2 dissociation:
- Reduce pathological ER calcium leak without affecting normal channel function
- In AD mouse models (3xTg-AD, [APP](/genes/app), Rycals improve:
- Synaptic plasticity ([LTP](/mechanisms/long-term-potentiation) restoration)
- Cognitive function (spatial memory tasks)
- Reduce [Aβ](/proteins/amyloid-beta) load and tau phosphorylation
- Normalize ER stress markers
- Rycals are in clinical development for cardiac indications and being evaluated for neurodegenerative applications
Dantrolene
- RyR antagonist that reduces ER calcium release
- Neuroprotective in AD mouse models; reduces [Aβ](/proteins/amyloid-beta) pathology and improves cognition
- FDA-approved for malignant hyperthermia; being repurposed for neurodegeneration research
- Limitations: Non-selective; affects muscle function; narrow therapeutic window
Combination Approaches
- RyR stabilization combined with anti-amyloid or anti-tau therapies
- Targeting upstream calcium entry channels ([NMDA receptor](/entities/nmda-receptor) receptor] receptor] receptors, voltage-gated calcium channels) alongside RyR
- Modulating ER calcium refilling via SERCA pump activators
RyR in Other Neurodegenerative Diseases
Huntington's Disease
- Mutant [huntingtin](/proteins/huntingtin) sensitizes RyR and IP3 receptors, causing ER calcium overload
- Contributes to [medium spiny neuron](/cell-types/medium-spiny-neurons) vulnerability in the [striatum](/brain-regions/striatum)
- Dantrolene protects striatal [neurons](/entities/neurons) in HD models
ALS
- RyR dysfunction in [motor neurons](/cell-types/motor-neurons) contributes to calcium-mediated [excitotoxicity](/entities/excitotoxicity)
- RyR1 expression changes in [spinal cord](/brain-regions/spinal-cord) motor [neurons](/entities/neurons) in ALS
Spinocerebellar Ataxias
- RyR1 mutations cause rare forms of cerebellar ataxia
- RyR1 dysfunction contributes to [Purkinje cell](/cell-types/purkinje-cells) degeneration
See Also
- [BACE1](/entities/bace1) ([Beta-Secretase
External Links
- [PubMed)](https://pubmed.ncbi.nlm.nih.gov/) — Biomedical literature database
- [Allen Brain Atlas](https://brain-map.org/) — Brain gene expression data
Background
The study of Ryanodine Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying [mechanisms of neurodegeneration](/mechanisms) and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- Allen Human Brain Atlas: [Ryanodine Receptor expression search](https://human.brain-map.org/microarray/search/show?search_term=Ryanodine+Receptor)
- Allen Mouse Brain Atlas: [Ryanodine Receptor search](https://mouse.brain-map.org/search/index.html?query=Ryanodine+Receptor)
- Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)
- BrainSpan Developmental Transcriptome: [Ryanodine Receptor developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=Ryanodine+Receptor)
References
[Bhatt AB, et al, Ryanodine receptors: physiological function and deregulation in [Alzheimer] disease (2014)
[Bhatt AB, et al, Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's Disease-like pathologies and cognitive deficits (2017)
[Bhatt AB, Bhatt AB, Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer's Disease (2021)
[Bhatt AB, et al, The role of ryanodine receptors in regulating neuronal activity and its connection to the development of Alzheimer's Disease (2023)
[Fill M, Bhatt JA, Ryanodine receptor calcium release channels (2002)
[Bhatt AB, et al, Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's Disease (2011)
[Bhatt M, Presenilin mutations and calcium signaling defects in the nervous system (2007)
[Bhatt AB, et al, Leaky ryanodine receptors and neurodegeneration: fixing the leak (2022)
[Bhatt AB, Bhatt JA, Calcium hypothesis of neurodegeneration and the role of ryanodine receptors (2020)
[Bhatt AB, et al, Pharmacological targeting of RyR2 calcium leak rescues Alzheimer's Disease phenotypes (2019)
Bhatt Y, Calcium signaling hypothesis: a non-negligible pathogenesis in [Alzheimer's disease (2025)